Journal of Hepatology
Volume 51, Issue 2 , Pages 398-402 , August 2009

Autoimmune pancreatitis/IgG4-associated cholangitis and primary sclerosing cholangitis – Overlapping or separate diseases?

  • George J.M. Webster

      Affiliations

    • Department of Gastroenterology, University College Hospital, 235 Euston Road, London NW1, UK
    • Institute of Hepatology, University College London, London, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 2073809162.
  • ,
  • Stephen P. Pereira

      Affiliations

    • Department of Gastroenterology, University College Hospital, 235 Euston Road, London NW1, UK
    • Institute of Hepatology, University College London, London, UK
  • ,
  • Roger W. Chapman

      Affiliations

    • Department of Gastroenterology and Hepatology, The John Radcliffe Hospital, Oxford, UK

  • Image Result

    Histology from the liver hilum in a patient with complex hilar stricturing and an associated mass. A diagnosis of IgG4-associated cholangitis was made. (A) H+E showing extensive fibrous stroma, with a

    Histology from the liver hilum in a patient with complex hilar stricturing and an associated mass. A diagnosis of IgG4-associated cholangitis was made. (A) H+E showing extensive fibrous stroma, with associated plasma cell infiltrate. (B) IgG4 immunostaining showing >20 IgG4+ plasma cells per high power film.

  • Image Result
    Cholangiographic response to steroid therapy in autoimmune pancreatitis/IgG4-associated cholangitis. (A) ERCP showing complex hilar stricture with associated intrahepatic biliary stricturing in a pati

    Cholangiographic response to steroid therapy in autoimmune pancreatitis/IgG4-associated cholangitis. (A) ERCP showing complex hilar stricture with associated intrahepatic biliary stricturing in a patient with biliary obstruction and raised serum IgG4. The patient also had renal impairment, focal renal abnormalities on imaging, and an IgG4+ plasma cell renal infiltrate. (B) Repeat ERCP 3 months following commencement of oral steroid therapy. Marked improvement in hilar and intrahepatic stricturing is seen.

 The authors who have taken part in this study declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.

PII: S0168-8278(09)00307-9

doi: 10.1016/j.jhep.2009.04.010

Journal of Hepatology
Volume 51, Issue 2 , Pages 398-402 , August 2009